Cases 1 - 10 of 221
MOMENTA PHARMACEUTICALS, INC. v. MYLAN PHARMACEUTICALS, INC. et al
as 2:2022cv00750
Plaintiff:
MOMENTA PHARMACEUTICALS, INC.
Defendant:
MYLAN PHARMACEUTICALS, INC., MYLAN, INC., VIATRIS, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00244
Plaintiff:
Pfizer Inc., Warner-Lambert Company LLC and PF Prism IMB B.V.
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00090
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00019
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
UCB, Inc. et al v. Mylan Technologies, Inc. et al
as 2:2019cv00148
Plaintiff:
UCB, Inc., LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH and others
Defendant:
Mylan Pharmaceuticals, Inc., Mylan Technologies, Inc. and Mylan, Inc.
Counter Claimant:
Mylan Technologies Inc.
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00101
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00097
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00632
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00037
Plaintiff:
Kaken Pharmaceutical Co., LTD., Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals Ireland LTD and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al
as 1:2018cv00202
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
